Page 36 - Read Online
P. 36
Furthermore, these biomarkers could also been applied for interface has come tighter and promising. However, the best
other tumors and even other neurological diseases, without result will come with the integration between technology
any contrast addition and increase of costs. [69,70] for resection and tumor nature knowledge.
For high-grade lesions with increased neo-vascularization, Financial support and sponsorship
there was a report with use of indocyanine green (ICG) Nil.
for detection of tumor borders. It is classically used by
ophthalmologists for retinal vasculature and more recently Conflicts of interest
for vascular neurosurgeries for aneurysms and arterio- There are no conflicts of interest.
venous malformations; however, for surgical borders for
high-grade gliomas, it is a novel technique. Eyüpoglu et REFERENCES
[71]
al. reported the ability of demonstrating the hypervascular
areas with ICG that were not visible with the 5-ALA use. 1. D’amico RS, Kennedy BC, Bruce JN. Neurosurgical oncology:
This technique was called dual intra-operative visualization advances in operative technologies and adjuncts. J Neurooncol
approach (DIVA) with the initial approach using 5-ALA; 2014;119:451-63.
after all initial tumor was resected, ICG was administered 2. Barone DG, Lawrie TA, Hart MG. Image guided surgery for the
for visualization of remaining hypervascularization areas, resection of brain tumours. Cochrane Database Syst Rev 2014; doi:
10.1002/14651858.
with good initial results. Further studies are needed, but 3. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte
DIVA technique could be an interesting approach for further F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K,
resection of non-fluorescein areas. [72] Michael C, Miller D, Sawaya R.. A multivariate analysis of 416
patients with glioblastoma multiforme: prognosis, extent of resection,
One of the most difficult tasks in glioma surgery is the and survival. J Neurosurg 2001; 95:190-8.
low-grade lesion. Most of the low-grades have similar 4. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An
density, echogenicity, and macroscopic aspect. Despite the extent of resection threshold for newly diagnosed glioblastomas. J
neuronavigation progression, there are few MRI methods 5. Neurosurg 2011;115:3-8.
Sanai N, Berger MS. Glioma extent of resection and its impact on
for low-grade tumor visualization, and most of the times the patient outcome. Neurosurgery 2008;62:753-64; discussion 264-6.
lesion is not contrast-enhanced and there is just the FLAIR 6. Vigneswaran K, Neill S, Hadjipanayis CG. Beyond the World
sequence for tumor borders. Ramakrishna et al. showed Health Organization grading of infiltrating gliomas: advances in
[73]
improvement of overall survival with aggressive resection the molecular genetics of glioma classification. Ann Transl Med
of FLAIR tumor limits, not only in the first attempt, but 2015;3:95.
also in reoperation, regardless of patient age, pathology, 7. Rudà R, Pellerino A, Magistrello M, Franchino F, Pinessi L, Soffietti
chemotherapy, and radiation. [74] R. Molecularly Based Management of gliomas in clinical practice.
Neurol Sci 2015;36:1551-7.
8. Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker
The 5-ALA for LGGs is usually reported as non-visible, but PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G,
it is not true for all of them. Valdés showed that 5/12 patients Caron AA, Kollmeyer TM,Praska CE, Chada AR, Halder C, Hansen
had at least 1 instance of visible fluorescence during surgery HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico
and 45% of the non-visible fluorescence had a higher and AR, O’Neill BP, Buckner JC, Giannini C, Huse JT,Perry A, Tihan T,
detectable concentration of PpIX in the tumor tissue after Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch
the 5-ALA administration. With this idea, other researches MR, Jenkins RB. Glioma Groups Based on 1p/19q, IDH and TERT
were made to accurate the visibility of the fluorescein, 9. Promoter Mutations in Tumors. N Engl Med 2015;372:2499-508.
Fontana EJ, Benzinger T, Cobbs C, Henson J, Fouke SJ. The evolving
or guide the elevated concentration in tissue with special role of neurological imaging in neuro-oncology. J Neurooncol
probes of light visualization or high-resolution microscopic 2014;119:491-502.
techniques, but with few results by this date. [75] 10. Johnson RD, Stacey RJ. The impact of new imaging technologies in
neurosurgery. Surgeon 2008; 6:344-9.
CONCLUSION 11. Grossman SA Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld
M, Fisher J. Survival of patients with newly diagnosed glioblastoma
treated with radiation and temozolomide in research studies in the
Evidences of the correlation between tumor removal United States. Clinical Cancer Res 2010;16:2443-9.
and increase of survival rate have an impulse in novel 12. Stupp R, Tonn JC, Brada M, Pentheroudakis G. ESMO Guidelines
technologies for safe resection and EOR. The uses of iMRI, Working Group.High-grade malignant glioma: ESMO Clinical
DTI, PET, iUS, and fluorescence guidance have come to Practice Guidelines for diagnosis, treatment and follow-up. Ann
establish the neuronavigation era in neurosurgery. Oncol 2010;21 Suppl 5:v190-3.
13. Stupp R, Hegi M, Weller. Neuro-oncology, a decade of temozolomide
and beyond. Expert Rev Anticancer Ther 2010;1675-7.
Also, there is an increasing importance of the tumor genetics 14. Dandy WE. Removal of right cerebral hemisphere for certain tumors
and behavior, which will provide crucial information and with hemiplegia: Preliminary report. JAMA 1928; 90:823-5.
will guide tumor resection and adjuvant treatment. Despite 15. Dandy WE. Physiological studies following extirpation of the right
all limitations of each technology and the lack of clear cerebral hemisphere in man. Bull Johns Hopkins Hosp 1933;53:31-51.
evidences, it is clear that this neurosurgeon/technology 16. Talacchi A, Santini B, Casagrande F, Alessandrini F, Zoccatelli G,
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ March 11, 2016 ¦ 77